Vishal Gulati
Lifesum named as one of the hottest startups in Europe Read More
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.

Archive for the ‘CNS’ Category

April 3, 2016

What we don’t know about the brain has a huge cost. Human and Financial

Forum Pharmaceuticals’ rare, high-risk strategy to launch ambitious late-stage trials for schizophrenia with a single major investor has ended in failure, triggering a company-wide reorganization. Source: With two PhIII schizophrenia trials in ruins and Alzheimer’s on hold, Forum chops staff and considers options – FierceBiotech Fierce Biotech is reporting major restructuring of Forum Pharma (previously […]